Rotterdam Centre for Tropical Medicine, Rotterdam, Netherlands.
Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University of Rotterdam, Rotterdam, Netherlands.
Lancet Infect Dis. 2016 Jan;16(1):100-112. doi: 10.1016/S1473-3099(15)00359-X.
Mycetoma can be caused by bacteria (actinomycetoma) or fungi (eumycetoma) and typically affects poor communities in remote areas. It is an infection of subcutaneous tissues resulting in mass and sinus formation and a discharge that contains grains. The lesion is usually on the foot but all parts of the body can be affected. The causative microorganisms probably enter the body by a thorn prick or other lesions of the skin. Mycetoma has a worldwide distribution but is restricted to specific climate zones. Microbiological diagnosis and characterisation of the exact organism causing mycetoma is difficult; no reliable serological test exists but molecular techniques to identify relevant antigens have shown promise. Actinomycetoma is treated with courses of antibiotics, which usually include co-trimoxazole and amikacin. Eumycetoma has no acceptable treatment at present; antifungals such as ketoconazole and itraconazole have been used but are unable to eradicate the fungus, need to be given for long periods, and are expensive. Amputations and recurrences in patients with eumycetoma are common.
足菌肿可由细菌(放线菌肿)或真菌(真菌肿)引起,通常影响偏远地区的贫困社区。它是一种皮下组织感染,导致肿块和窦道形成,并排出含有颗粒的分泌物。病变通常在脚上,但身体的所有部位都可能受到影响。致病微生物可能通过刺伤或皮肤的其他损伤进入体内。足菌肿分布广泛,但仅限于特定的气候带。微生物学诊断和确切引起足菌肿的生物体的特征描述很困难;目前没有可靠的血清学检测方法,但用于鉴定相关抗原的分子技术显示出了希望。放线菌肿用抗生素疗程治疗,通常包括复方磺胺甲噁唑和阿米卡星。目前真菌肿没有可接受的治疗方法;已经使用了酮康唑和伊曲康唑等抗真菌药物,但这些药物无法根除真菌,需要长期使用,而且价格昂贵。真菌肿患者常发生截肢和复发。